DRKS00008183已完成不适用
on-interventional study to evaluate neurotoxicity under therapy with Docetaxel Omnicare for patients with various tumor entities - NORDIC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 109
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Male and female patients = 18 years
- •2. Diagnosis of tumor disease for which a chemotherapy with Docetaxel Omnicare is indicated
- •3. Investigator's decision (independent of study participation) to treat the patient with Docetaxel Omnicare®
- •4. Sufficient patient's compliance upon investigator's assessment
- •5. Written informed consent of the patient to retrospective and prospective pseudonomized documentation, to forwarding and analysis of the data and to access to the data within monitoring
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Klinische Studie zur Überprüfung der Auswirkungen einer präoperativen Verabreichung von Glutamin und/oder Omega-3-Fettsäuren auf das Inflammationsgeschehen nach aortokoronaren Bypassoperationen - Inflammation-Bypassoperation-StudieIndikationsstellung für eine aortokoronare BypassoperationEUCTR2008-003971-30-ATniv.-Prof. Dr. Karlheinz Tscheliessnigg
已完成
3 期
A clinical trial to study the effect of two different radiotherapy treatment techniques in patients with cancer cervixCTRI/2018/05/014021POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH80
尚未招募
3 期
A Prospective randomized study to compare haematological toxicities and response between two different chemotherapy regimens in chemoradiotherapy treatment of carcinoma of uterine cervix.CTRI/2024/08/072198SRI VENKATESHWARA INSTITUTE OF MEDICAL SCIENCES
进行中（未招募）
1 期
The evaluation of safety and biological effects of cancer-killing virus vaccine given to patients with advanced brain tumoursMalignant neoplasm of brain, high-grade brain tumourMalignant neoplasm of brainCancerISRCTN51762486niversity of Leeds12
进行中（未招募）
1 期
A clinical study to evaluate the effect of rimantadine in patients with hepatitis C virus (HCV) infection alongside standard treatment with pegylated interferon and ribavirin.EUCTR2011-002781-21-GBeeds Teaching Hospitals22